White Papers

White paper DCT Checklist cover page

DCT Planning Checklist: Your Guide to Ensuring a Successful Decentralized or Hybrid Trial

Even before the COVID-19 pandemic spotlighted the benefits of decentralized clinical trials (DCTs), their use was becoming more commonplace. After witnessing the ability of DCTs to rescue a number of clinical trials that were in jeopardy as a result of participants being unwilling or unable to safely travel to clinical sites, more sponsors and CROs are taking note of how a mobile approach could benefit their trials.

White paper Five Misconceptions cover page

Decentralized Trials Are Better Understood, But 5 Misconceptions Persist

Even though decentralized clinical trials (DCTs) have existed for almost 20 years, many sponsors and CROs hesitated to employ them for a variety of reasons, including discomfort due to a lack of familiarity. But the COVID-19 pandemic changed that.

White paper Diversity in Trials cover page

The FDA Steps Up Pressure on Sponsors to Increase Diversity in Clinical Trials: How Decentralized Trials Can Help

The FDA has been advocating for increased diversity in clinical trials for decades but, by its own account, little progress has been made and certain groups remain woefully underrepresented in many studies. But could we now be at a turning point where talk about increasing diversity and inclusiveness translates into action and real change occurs? All indications point to “yes”, with the FDA issuing a second set of guidelines for how study sponsors can increase racial and ethnic diversity in clinical trials.

White paper Lessons Learned cover page

How Sponsors and CROs can Fully Benefit from the Permanent Shift to Decentralized Clinical Trials Brought About by the COVID-19 Pandemic

To aid sponsors and CROs in fully realizing the benefits of decentralized clinical trial methods moving forward, this whitepaper extracts the lessons learned from the pandemic and their implications for clinical trials now and in the future.

Please sign up to receive more case studies, white papers, and other PCM Trials resources here.

PCM Trials will be creating more resources as our clinical trials are completed. We have other resources such as webinars, videos, and PCM Trials in the news information you can subscribe to.

"*" indicates required fields

Affirmative Marketing Opt-Ins*
Please select how you would like to hear from PCM TRIALS in the future. Communications may include newsletters, webinar offers, and announcements we believe will interest you:
This field is for validation purposes and should be left unchanged.